Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs Hyperliquid (HYPE) Price & Performance

Bio ProtocolTrade
HyperliquidTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs Hyperliquid — how do they compare? Bio Protocol trades at Rp513.8 (market cap Rp1,16T, Rp252,63M 24h volume), while Hyperliquid trades at Rp1,158,949 (market cap Rp293,38T, Rp5,88T 24h volume). The key difference: Hyperliquid is far larger — about 252.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 253,1M / 953,3M HYPE (27%) for Hyperliquid. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Hyperliquid for 34 Days on average.

BIOHYPE
Market Cap
Rp1,16TRp293,38T
Volume (24h)
Rp252,63MRp5,88T
Circulating Supply
2,2B / 3,3B BIO (68%)253,1M / 953,3M HYPE (27%)
Typical Hold Time
16 Days34 Days

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
0% Buy100% Sell
Avg holding period · 16 Days
HYPE
86% Buy14% Sell
Avg holding period · 34 Days

Top news

Latest headlines on both assets

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About Hyperliquid

Hyperliquid is an advanced blockchain platform designed to improve the efficiency and performance of decentralized finance (DeFi) applications. It is built on a custom Layer 1 blockchain that has been specifically engineered for optimal scalability and speed. A key feature of its design is HyperBFT, a proprietary consensus mechanism that provides rapid transaction finality while ensuring high security standards.

Read more on HYPE